Oncology Central

Eribulin for the treatment of metastatic breast cancer: a top of the table chemotherapy option?


Chris Twelves speaks to Roshaine Gunawardana, Commissioning Editor: Professor Twelves is Professor of Clinical Cancer Pharmacology and Oncology and heads the Section of Oncology and Cancer Research (Clinical) at the Leeds Institute of Cancer and Pathology (Leeds, UK). He is a medical oncologist with a particular interest in new drug development and clinical pharmacology; his clinical practice has been in colorectal and breast cancer. After training as an oncologist in London he was Senior Lecturer, then Reader, in Medical Oncology in Glasgow at the Beatson Oncology Centre (Glasgow, UK) before taking up his current post at the University of Leeds and Leeds Teaching Hospitals Trust (Leeds, UK).

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.